Milliman Healthcare Inflation Plus ETF
Milliman Healthcare Inflation Plus ETF reported 65 holdings worth US$994K as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 26, 2026
Milliman Healthcare Inflation Plus ETF reported 65 holdings worth US$994K as of Jun 30, 2026. Largest: Eli Lilly And Company, Unitedhealth Group Incorporated and Johnson & Johnson. Filed Aug 26, 2026 (Form N-PORT).
- Holdings
- 65
- Value as reported
- US$994K
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 36 | US$43,179 | 4.3% |
| Unitedhealth Group Incorporated | 90 | US$37,407 | 3.8% |
| Johnson & Johnson | 104 | US$26,413 | 2.7% |
| Thermo Fisher Scientific Inc | 52 | US$26,071 | 2.6% |
| Abbott Laboratories | 239 | US$21,687 | 2.2% |
| Intuitive Surgical, Inc. | 50 | US$19,884 | 2.0% |
| Danaher Corporation | 98 | US$18,667 | 1.9% |
| Stryker Corporation | 53 | US$16,687 | 1.7% |
| Merck & Company, Inc. | 121 | US$15,549 | 1.6% |
| Medtronic Plc. | 178 | US$13,925 | 1.4% |
| Cvs Health Corporation | 124 | US$12,828 | 1.3% |
| Abbvie Inc. | 44 | US$11,072 | 1.1% |
| Boston Scientific Corporation | 215 | US$9,176 | 0.92% |
| Mckesson Corporation | 12 | US$9,067 | 0.91% |
| Hca Healthcare, Inc. | 23 | US$8,967 | 0.90% |
| Elevance Health, Inc. | 22 | US$8,508 | 0.86% |
| Bristol-myers Squibb Company | 146 | US$8,413 | 0.85% |
| The Cigna Group | 27 | US$7,443 | 0.75% |
| Edwards Lifesciences Corporation | 79 | US$7,146 | 0.72% |
| Becton, Dickinson And Company | 39 | US$5,902 | 0.59% |
| Idexx Laboratories, Inc. | 11 | US$5,791 | 0.58% |
| Cencora, Inc. | 20 | US$5,660 | 0.57% |
| Cardinal Health, Inc. | 23 | US$5,464 | 0.55% |
| Agilent Technologies, Inc. | 40 | US$5,313 | 0.53% |
| Humana Inc. | 13 | US$5,164 | 0.52% |
| Natera, Inc. | 19 | US$5,158 | 0.52% |
| United Therapeutics Corporation | 9 | US$4,876 | 0.49% |
| Waters Corporation | 13 | US$4,876 | 0.49% |
| Medline Inc. | 123 | US$4,851 | 0.49% |
| Iqvia Holdings, Inc. | 24 | US$4,637 | 0.47% |
| Madrigal Pharmaceuticals, Inc. | 8 | US$4,296 | 0.43% |
| Veeva Systems Inc. | 24 | US$4,259 | 0.43% |
| Ge Healthcare Technologies Inc. | 66 | US$4,225 | 0.42% |
| Revolution Medicines, Inc. | 22 | US$4,120 | 0.41% |
| Resmed Inc. | 20 | US$3,898 | 0.39% |
| Illumina, Inc. | 22 | US$3,868 | 0.39% |
| Dexcom, Inc. | 57 | US$3,839 | 0.39% |
| Mettler-toledo International, Inc. | 3 | US$3,833 | 0.39% |
| Moderna, Inc. | 54 | US$3,782 | 0.38% |
| West Pharmaceutical Services, Inc. | 10 | US$3,590 | 0.36% |
| Quest Diagnostics Incorporated | 16 | US$3,391 | 0.34% |
| Labcorp Holdings Inc. | 12 | US$3,360 | 0.34% |
| Amgen Inc. | 9 | US$3,259 | 0.33% |
| Centene Corporation | 49 | US$3,145 | 0.32% |
| Neurocrine Biosciences, Inc. | 18 | US$3,034 | 0.31% |
| Steris Plc (ireland) | 14 | US$2,948 | 0.30% |
| Guardant Health, Inc. | 18 | US$2,701 | 0.27% |
| Zimmer Biomet Holdings, Inc. | 27 | US$2,324 | 0.23% |
| Medpace Holdings, Inc. | 4 | US$2,118 | 0.21% |
| The Cooper Companies, Inc. | 28 | US$2,008 | 0.20% |
| Solventum Corporation | 25 | US$1,929 | 0.19% |
| Brightspring Health Services, Inc. | 26 | US$1,813 | 0.18% |
| Gilead Sciences, Inc. | 14 | US$1,769 | 0.18% |
| Align Technology, Inc. | 10 | US$1,687 | 0.17% |
| Tenet Healthcare Corporation | 9 | US$1,684 | 0.17% |
| Revvity, Inc. | 15 | US$1,669 | 0.17% |
| Penumbra, Inc. | 5 | US$1,579 | 0.16% |
| Insulet Corporation | 10 | US$1,523 | 0.15% |
| Alnylam Pharmaceuticals, Inc. | 5 | US$1,505 | 0.15% |
| Globus Medical, Inc. | 18 | US$1,422 | 0.14% |
| Pfizer, Inc. | 59 | US$1,421 | 0.14% |
| Davita Inc. | 6 | US$1,335 | 0.13% |
| Vertex Pharmaceuticals Incorporated | 1 | US$497 | 0.05% |
| Viatris Inc. | 23 | US$365 | 0.04% |
| Zoetis Inc. | 5 | US$359 | 0.04% |
Source
View original at SEC
Related